Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

NCT05945524 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05945524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Recruiting
Start date
September 28, 2023
Completion date
May 31, 2026
Enrollment
100 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma